FI120538B - Kelater, kelaterande föreningar och konjugater deriverad av dem - Google Patents
Kelater, kelaterande föreningar och konjugater deriverad av dem Download PDFInfo
- Publication number
- FI120538B FI120538B FI20070677A FI20070677A FI120538B FI 120538 B FI120538 B FI 120538B FI 20070677 A FI20070677 A FI 20070677A FI 20070677 A FI20070677 A FI 20070677A FI 120538 B FI120538 B FI 120538B
- Authority
- FI
- Finland
- Prior art keywords
- group
- ester
- moiety
- ooc
- carboxylic
- Prior art date
Links
- 239000002738 chelating agent Substances 0.000 title claims description 61
- -1 4,6-dichloro-1,3,5-triazin-2-ylamino, pyridyldithio Chemical group 0.000 claims description 56
- 238000003786 synthesis reaction Methods 0.000 claims description 54
- 230000015572 biosynthetic process Effects 0.000 claims description 53
- 239000013522 chelant Substances 0.000 claims description 41
- 108091034117 Oligonucleotide Proteins 0.000 claims description 30
- 125000002541 furyl group Chemical group 0.000 claims description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 27
- 150000002148 esters Chemical class 0.000 claims description 26
- 125000001544 thienyl group Chemical group 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 24
- 150000001408 amides Chemical class 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 102000015636 Oligopeptides Human genes 0.000 claims description 19
- 108010038807 Oligopeptides Proteins 0.000 claims description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 19
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 18
- 125000005647 linker group Chemical group 0.000 claims description 17
- 125000004076 pyridyl group Chemical group 0.000 claims description 16
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 15
- 125000006239 protecting group Chemical group 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 150000007513 acids Chemical class 0.000 claims description 12
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 12
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 239000007790 solid phase Substances 0.000 claims description 11
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- 150000004820 halides Chemical class 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 229910052693 Europium Inorganic materials 0.000 claims description 9
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Chemical class Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 8
- 229910021645 metal ion Inorganic materials 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 229910021644 lanthanide ion Inorganic materials 0.000 claims description 7
- 239000003446 ligand Substances 0.000 claims description 7
- 125000005907 alkyl ester group Chemical group 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 6
- 102000040430 polynucleotide Human genes 0.000 claims description 6
- 239000002157 polynucleotide Substances 0.000 claims description 6
- 150000003457 sulfones Chemical class 0.000 claims description 6
- 150000003459 sulfonic acid esters Chemical class 0.000 claims description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 5
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 5
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 229910052772 Samarium Inorganic materials 0.000 claims description 4
- 229910052771 Terbium Inorganic materials 0.000 claims description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001345 alkine derivatives Chemical class 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 4
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 150000003254 radicals Chemical group 0.000 claims description 4
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims description 4
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- 150000003456 sulfonamides Chemical class 0.000 claims description 4
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 claims description 4
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- 150000003568 thioethers Chemical class 0.000 claims description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 4
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 3
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 claims description 3
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 3
- 150000002540 isothiocyanates Chemical class 0.000 claims description 3
- 239000011859 microparticle Substances 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 claims description 2
- 229930024421 Adenine Natural products 0.000 claims description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- GSFVFRFSBSNYNG-UHFFFAOYSA-N O-azidohydroxylamine Chemical compound NON=[N+]=[N-] GSFVFRFSBSNYNG-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 229960000643 adenine Drugs 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 229940104302 cytosine Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 150000007970 thio esters Chemical class 0.000 claims description 2
- 229940113082 thymine Drugs 0.000 claims description 2
- 229940035893 uracil Drugs 0.000 claims description 2
- 125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 claims 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 125000002015 acyclic group Chemical group 0.000 claims 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 2
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 125000005920 sec-butoxy group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 52
- 150000001875 compounds Chemical class 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 238000001425 electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 27
- 239000007983 Tris buffer Substances 0.000 description 23
- 238000000034 method Methods 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
- 239000000741 silica gel Substances 0.000 description 19
- 229910002027 silica gel Inorganic materials 0.000 description 19
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 17
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 229910052747 lanthanoid Inorganic materials 0.000 description 16
- 150000002602 lanthanoids Chemical class 0.000 description 16
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 16
- LNBHUCHAFZUEGJ-UHFFFAOYSA-N europium(3+) Chemical compound [Eu+3] LNBHUCHAFZUEGJ-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 12
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 239000003208 petroleum Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 238000002372 labelling Methods 0.000 description 10
- 229910052786 argon Inorganic materials 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000003556 assay Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 230000005284 excitation Effects 0.000 description 7
- 238000004020 luminiscence type Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 238000010532 solid phase synthesis reaction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- OJCPLXMATFTJAT-UHFFFAOYSA-N 2-[6-(4-aminophenoxy)hexyl]propane-1,3-diol Chemical compound NC1=CC=C(OCCCCCCC(CO)CO)C=C1 OJCPLXMATFTJAT-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- OPRGEKRHMSUWBT-UHFFFAOYSA-N dimethyl 2-(6-hydroxyhexyl)propanedioate Chemical compound COC(=O)C(C(=O)OC)CCCCCCO OPRGEKRHMSUWBT-UHFFFAOYSA-N 0.000 description 3
- XBMAFXQXOQEULA-UHFFFAOYSA-N dimethyl 2-(6-trityloxyhexyl)propanedioate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OCCCCCCC(C(=O)OC)C(=O)OC)C1=CC=CC=C1 XBMAFXQXOQEULA-UHFFFAOYSA-N 0.000 description 3
- GFXIBCTZWFDFSX-UHFFFAOYSA-N dimethyl 2-[6-(4-nitrophenoxy)hexyl]propanedioate Chemical compound COC(=O)C(C(=O)OC)CCCCCCOC1=CC=C([N+]([O-])=O)C=C1 GFXIBCTZWFDFSX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- ZLOUCFITKUBZDA-UHFFFAOYSA-N ethyl 6-(hydroxymethyl)-4-iodopyridine-2-carboxylate Chemical compound CCOC(=O)C1=CC(I)=CC(CO)=N1 ZLOUCFITKUBZDA-UHFFFAOYSA-N 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- UZGLIIJVICEWHF-UHFFFAOYSA-N octogen Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)CN([N+]([O-])=O)C1 UZGLIIJVICEWHF-UHFFFAOYSA-N 0.000 description 3
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000012746 preparative thin layer chromatography Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- DOSGOCSVHPUUIA-UHFFFAOYSA-N samarium(3+) Chemical compound [Sm+3] DOSGOCSVHPUUIA-UHFFFAOYSA-N 0.000 description 3
- AJJYHJOOPKXECZ-UHFFFAOYSA-N tert-butyl n-[4-[8-hydroxy-7-(hydroxymethyl)octoxy]phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(OCCCCCCC(CO)CO)C=C1 AJJYHJOOPKXECZ-UHFFFAOYSA-N 0.000 description 3
- ITWBWJFEJCHKSN-UHFFFAOYSA-N 1,4,7-triazonane Chemical compound C1CNCCNCCN1 ITWBWJFEJCHKSN-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 101710178035 Chorismate synthase 2 Proteins 0.000 description 2
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 2
- 101710152694 Cysteine synthase 2 Proteins 0.000 description 2
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 2
- OPCIHVVDMSLUOK-UHFFFAOYSA-N diethyl 4-iodopyridine-2,6-dicarboxylate Chemical compound CCOC(=O)C1=CC(I)=CC(C(=O)OCC)=N1 OPCIHVVDMSLUOK-UHFFFAOYSA-N 0.000 description 2
- IOIFRTZBJMZZFO-UHFFFAOYSA-N dysprosium(3+) Chemical group [Dy+3] IOIFRTZBJMZZFO-UHFFFAOYSA-N 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- STCBLHRJWCCQSC-UHFFFAOYSA-K europium(3+);2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Eu+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O STCBLHRJWCCQSC-UHFFFAOYSA-K 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- HKCRVXUAKWXBLE-UHFFFAOYSA-N terbium(3+) Chemical compound [Tb+3] HKCRVXUAKWXBLE-UHFFFAOYSA-N 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- 150000003577 thiophenes Chemical class 0.000 description 2
- DLQYXUGCCKQSRJ-UHFFFAOYSA-N tris(furan-2-yl)phosphane Chemical compound C1=COC(P(C=2OC=CC=2)C=2OC=CC=2)=C1 DLQYXUGCCKQSRJ-UHFFFAOYSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- FJSKXQVRKZTKSI-UHFFFAOYSA-N 2,3-dimethylfuran Chemical compound CC=1C=COC=1C FJSKXQVRKZTKSI-UHFFFAOYSA-N 0.000 description 1
- JFXXYKVSLHRBAA-UHFFFAOYSA-N 2,4-dimethylfuran-3-carboxylic acid Chemical compound CC1=COC(C)=C1C(O)=O JFXXYKVSLHRBAA-UHFFFAOYSA-N 0.000 description 1
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 1
- VNJOEUSYAMPBAK-UHFFFAOYSA-N 2-methylbenzenesulfonic acid;hydrate Chemical compound O.CC1=CC=CC=C1S(O)(=O)=O VNJOEUSYAMPBAK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- IHCCAYCGZOLTEU-UHFFFAOYSA-N 3-furoic acid Chemical compound OC(=O)C=1C=COC=1 IHCCAYCGZOLTEU-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- JVCWTTKJXQPITQ-UHFFFAOYSA-N 4-bromopyridine-2,6-dicarboxylic acid Chemical compound OC(=O)C1=CC(Br)=CC(C(O)=O)=N1 JVCWTTKJXQPITQ-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 229910020667 PBr3 Inorganic materials 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 229940125907 SJ995973 Drugs 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000005598 Sharpless reaction Methods 0.000 description 1
- 241001231783 Teira Species 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- SWSKYBRWRDKULI-UHFFFAOYSA-N [6-bromohexoxy(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OCCCCCCBr)C1=CC=CC=C1 SWSKYBRWRDKULI-UHFFFAOYSA-N 0.000 description 1
- SDBCOOLMAMVEHT-UHFFFAOYSA-M [O-]C(C1=NC=CC=C1)=O.[Eu+3] Chemical compound [O-]C(C1=NC=CC=C1)=O.[Eu+3] SDBCOOLMAMVEHT-UHFFFAOYSA-M 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- XTEOJPUYZWEXFI-UHFFFAOYSA-N butyl n-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate Chemical compound S1C(CC(C)C)=CC(C=2C=CC(CN3C=NC=C3)=CC=2)=C1S(=O)(=O)NC(=O)OCCCC XTEOJPUYZWEXFI-UHFFFAOYSA-N 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- 230000002327 eosinophilic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- FSAYXJJXLGNURQ-UHFFFAOYSA-N ethyl 4-bromo-6-(hydroxymethyl)pyridine-2-carboxylate Chemical compound CCOC(=O)C1=CC(Br)=CC(CO)=N1 FSAYXJJXLGNURQ-UHFFFAOYSA-N 0.000 description 1
- GQDICYLHLGZWDC-UHFFFAOYSA-N ethyl 4-iodo-6-(oxan-2-yloxymethyl)pyridine-2-carboxylate Chemical compound CCOC(=O)C1=CC(I)=CC(COC2OCCCC2)=N1 GQDICYLHLGZWDC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000005244 familial abdominal 2 aortic aneurysm Diseases 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- UVRRIABXNIGUJZ-UHFFFAOYSA-N methyl 2-methylfuran-3-carboxylate Chemical compound COC(=O)C=1C=COC=1C UVRRIABXNIGUJZ-UHFFFAOYSA-N 0.000 description 1
- XZMHJYWMCRQSSI-UHFFFAOYSA-N n-[5-[2-(3-acetylanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound CC(=O)C1=CC=CC(NC=2SC=C(N=2)C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=C1 XZMHJYWMCRQSSI-UHFFFAOYSA-N 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 1
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 238000001776 time-resolved fluorescence quenching Methods 0.000 description 1
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 101150061972 zur gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
Claims (20)
1. Kelat omfattande
1 I - en lantanidjon, Ln , 5. en strukturell kromofordel, - en kelaterande del som omfattar minst tvä karboxylsyra- eller fosfonsyragrupper eller estrar, amider eller sait därav, som är fästa tili en aromatisk enhet i den strukturella kromofordelen antingen direkt eller via en cyklisk eller acyklisk kolvätekedja som innehäller N samt 10. en reaktiv grupp A som är kopplad tili den strukturella kromofordelen eller tili den kelaterande delen antingen direkt eller via en linker L, varvid gruppen A tillhandahäller bindning tili en biomolekyl eller tili en funktionell grupp pä en fast fas, eller vilken grupp inte är närvarande, varvid iv. den reaktiva gruppen A är vald bland en grupp som bestär av isotiocyanat, 15 bromacetamid, jodacetamid, maleinimid, 4,6-diklor-l,3,5-triazin-2-ylamin, pyridylditi, tioester, aminooxi, azid, hydrazid, amino, alkyn, en polymeriserande del och en karboxylsyra eller syraklorid eller en aktiv ester av dessa eller O UN NH A" ^ • · • · · : .·. 20 • · · ··· .···. väri A’ är en lämnande ligand, säsom Cl, (CH3)2SO, H2O och NO3 och väri • · ·· · - är linkern L:s position, • ·· .·**. v. linkern L är bildad av mellan en och tio strukturella delar, av vilka varje strukturell • · · del är vald bland en grupp som bestär av fenylen, alkylen med 1-12 kolatomer, 25 etynydiyl (-C=C-), etylendiyl (-C=C-), eter (-0-), tioeter (-S-), amid (-CO-NH-, • « :***: -CO-NR’-, -NH-CO- och -NR’-CO-), karbonyl (-CO-), ester (-COO- och -OOC-), • · · .V. disulfid (-SS-), sulfonamid (-SO2-NH-, -SO2-NR’-), sulfon (-SO2-), fosfat • ♦ · • · .···. (-O-PO2-O-), diaza (-N=N-) och tertiär amin, väri R’ representerar en alkylgrupp, ♦ ·1 * , som innehäller färre än 5 kolatomer, ·#·«« • · ... 30 vi. den strukturella kromofordelen omfattar en eller Hera aromatiska enheter, av vilka • · • · minst en aromatisk enhet är en pyridylgrupp som är substituerad med furyl eller tienyl, väri furyl- eller tienylgruppen är substituerad med en eller flera likadana eller olika elektronavgivande grupper och därtill eventuellt ocksä med karboxyl-eller sulfonsyragrupper eller estrar, amider eller salt av dessa syror, G, och väri de strukturella kromofordelama är direkt kopplade till varandra, sä att de bildar en terpyridylgrupp eller är kopplade till varandra via en cyklisk eller icke-cyklisk 5 kolvätekedja som innehäller N.
2. Kelat enligt krav l,kännetecknad av att den är vald bland gruppen som bestär av strukturema 10 • · • · • · · • · • · • · · • · · • · · • · · • · · • · • · • · · • · • · • · · • · · • · • · • · · • · • · · • · · • · ··· • · • · • · · • · • · · • · · • · • · · • · • · • · · • · · · · φ · 1 · · • · • · • · · „YR, Υγ t %R, „feR, A, ΑΛΑ rY XV YYVi rW"z γνί äAh%-a o o O o O O R2\Qt 1 O S N-s O O O o O O K Y~~R1 O O OOC N ^ P oooooo 1 oo - I ’ ’ ' f\i N‘ Il f N 1 ΌΟΟ^Χ^βζ r G A AN g R2YYri s£\z <Ρλζ Γ Y Γ Y <p\Z R2&-D1 λ R2\Y-r1 COO-COO-COO-COO· R2\0,^r1 I R A I X GV\ GvG^ iYi L f\\ rfi r2^0-?. r2^0£. 1 γ YYo- a,” f γνί Ln* γ"ί ΛΥ'μ ΛνΥ^Λ I ί li -ooAYY ζν\^-Υ II M 11 II I-1 I f I 0. o 5 OOC 1 COO- S S SS jl Xv\ coo‘ 15 cj ^ O 'ooc VYR1 a-l-g . GYz g . a-l-g a aa r2¥ri r2¥ri R%Y Y^COO- RYR,i Y^COO- YQLnvXX, /x££ AA n y o ΌοΑν^Ν_N> -OOC N^N_S o o o o Λ AG 9 q 99 ... ooc r&r, -ooc K=YR, • · · • · * · · A-L-G /v • R2^).? Y\R a-l-g^ %γζ A-l-g. Hl R2AR1 RAr1 *···’ d2Yyz f'N'^coo- I R ·· r2YY-ri Π η Γ n r il L:· A /XK^ rVW-A :...: -oocPY'US ^ Ln„ rNfLTN1 -’· ΓΝΊ fA'y"\ Il 1 1 O O O O ^ MR1 SS SS§8 OO As. JiXvY OO o O o o oo .·.·. Ooc'^Yöpz o o o o q q *.·.* R ^"G-L-A • · · • · • · • · · | f 1 -s : : : väri R och R är grupper som avger elektroner, L, G, R’ och A har samma betydelse som i ··* : γ krav 1 och Z är antingen O eller S for furyl- respektive tienylgruppens vidkommande. • · · · · 3 • · .***. 3. Kelat enligt krav 1, kännetecknad avatt den bestär av strukturema • · · G A-L-G^ R2Ö-R1 r2^ri r^£r, r^j° «Μ.χΧ ΛνΛ L-A M. / N \ I l k InM X 1 MM oocMnMn_X oocM^/N_jS °°ΜΜ -ooc^X£ri te. ,, . "S" ".te, ril r2M l XMcoo- Λ g-\ XX R X^r1 v X a-l-g^ XX r2X),z , f N coo- Jk ΑνΛ 2X)Z Xn^coo- R M~R1 /J^^^L-A ink Ln31 > R M R1 /J/\ / N J JL m n / N \ Ml k LnX OO^N^I_|k Ml < Ln3+> OOC'^N'X^ L_X N |]g 'OOC^N^~^L_jS aX MX χΧ R Vtel^Ri K V^,—g_L-a väri R1 och R2 är grupper som avger elektroner, L, G, R’ och A har samma betydelse som i krav 1 och Z är antingen O eller S for furyl- respektive tienylgruppens vidkommande. 5
4. Kelat enligt krav l-3,kännetecknad avatt lantanidjonen Ln3+ är europium, • · : 1·· samarium, terbium eller dysprosium. • · • · • i1 • · · # li *·!.1 5. Kelat enligt krav 4, kännetecknad av att lantanidjonen Ln är europium eller • · · • · ’···1 10 samarium. • · • · • · · • · · • · ’···1 6. Kelat enligt nägot av kraven 1-5, kännetecknad av att gruppema som avger . . elektroner är valda bland gruppen metyl, etyl, «-propyl, /-propyl, «-butyl, /-butyl, sec- • · · • · · !.1 butyl, metoxi, etoxi, «-propoxi, /-propoxi, «-butoxi, /-butoxi och .sec-butoxi. • · is • · • · · '·1·“ 7. Kelaterande ämne som omfattar • · · • · ’···1 - en strukturell kromofordel, - en kelaterande del som omfattar minst tvä karboxylsyra- eller fosfonsyragrupper ··· eller estrar, amider eller salt därav, som är fasta till en aromatisk enhet i den 20 strukturella kromofordelen antingen direkt eller via en cyklisk eller acyklisk kolvätekedja som innehäller N samt - en reaktiv grupp A som är kopplad till den strukturella kromofordelen eller till den kelaterande delen antingen direkt eller via en linker L, varvid gruppen A tillhandahäller bindning till en biomolekyl eller till en funktionell grupp pä en fast fas, varvid 5 i. den reaktiva gruppen A är en karboxylsyra eller syraklorid eller en aktiv ester av dessa eller -CH(NHR3)R4 väri R3 en tillfallig skyddsgrupp och R4 är en karboxylsyra eller ett salt, syrahalid eller ester därav, ii. linkem L är bildad av mellan en och tio strukturella delar, av vilka varje strukturell del är vald bland en grupp som bestär av fenylen, alkylen med 1-12 10 kolatomer, etynydiyl (-OC-), etylendiyl (-C=C-), eter (-0-), tioeter (-S-), amid (-CO-NH-, -CO-NR’-, -NH-CO- och -NR’-CO-), karbonyl (-CO-), ester (-COO-ja -OOC-), disulfid (-SS-), sulfonamid (-S02-NH-, -S02-NR’-), sulfon (-SO2-), fosfat (-O-PO2-O-), diaza (-N=N-) och tertiär amin, väri R’ representerar en alkylgrupp, som innehäller färre än 5 kolatomer, 15 iii. den strukturella kromofordelen omfattar en eller flera aromatiska enheter, av vilka minst en aromatisk enhet är en pyridylgrupp som är substituerad med furyl eller tienyl, vari furyl- eller tienylgruppen är substituerad med en eller flera likadana eller olika elektronavgivande grupper och därtill eventuellt ocksä med karboxyl- eller sulfonsyragrupper eller estrar, amider eller salt av dessa • · • · • ** 20 syror, G, och väri de strukturella kromofordelama är direkt kopplade till • · • I’ varandra sa att de bildar en terpyridylgrupp eller är kopplade till varandra via en • · · ··· cyklisk eller icke-cyklisk kolvätekedja som innehäller N. • · • · • · · • · • · ·
8. Kelaterande ämne enligt krav 7, kännetecknad av att gruppema som avger • · • · 25 elektroner är valda bland gruppen metyl, etyl, u-propyl, /'-propyl, n-butyl, t-butyl, sec- . . butyl, metoxi, etoxi, n-propoxi, /'-propoxi, u-butoxi, /-butoxi och ,sec-butoxi. • · · • · · • · • · • · t
9. Kelaterande ämne enligt krav 7, kännetecknad av att det är valt bland grupper • · · som bestär av strukturema *·:** 30 • · · ·» • · 1 · · * · • · • · · -f, *&R, rO^i , A- a"ltni γνί rNi —w γνί λ ΥΛ hn'l-a R2\Q6R1 *x *t R-^N^L_S Ä I N I %$Z 2%z rN"i γνί %tz ^r1 ΛλΛ oÄ A *&*.<*&« Λ Λ Λ ί Λ η η Λ, ? I Τ I R-^N'L^NL_JN'| χ/Τ Is Is A R ( J J J J R-AJfc, nT W nT ro R2^V-Ai^ 1 Φ* 3¾. r°€>?R, Α^·· iXX-y^O^ .xao ,απ n * n -5¾ -A^ ·· • · • · · • : *·· A'LG'rAz ^ζΑζ . .·. R2&-ri r2^ri I u li 1 X J-L JL-L 1 *···* ΑΝ<>1—^Ν'^—1^Ν'ΛΝ • · m m A-,t\L =..: r i r ί τι n :: ii A i ' » » * * • · · ; J ; * ' • · · • · · 12 Ά* väri R och R2 är grupper som avger elektroner, L har samma betydelse som i krav 7, och • · **;·* skyddsgruppen R3 är vald bland en grupp som bestär av gruppema Fmoc, Boc eller Bsmoc, *.:. · 5 och R’ ’ är en alkylester eller en allylester och R” ’ är en alkylgrupp, och väri Z är antingen • · · *...* 0 eller S, och G' är en ester eller en amid av en karboxyl- eller sulfonsyra. ··· • · · • · · « · som bestar av :.*·· 10. Kelaterande ämne enligt krav 7, kännetecknad av att det är valt bland en grupp AA' r%2"r. Xl g- Λ r^r, Λ l.ar· r2^r1 |Vy» Λ ΛΧ arm h%-a ,..1¾ < T II G· X . .../Vvftz r2^-r' r A-L-G w Q- r2^2£ri R2^R1 .¾¾ Ä.jA Ä ^ Λ7Λ R ΑνΛ^Ν^Ν rAnAn Ns f|lG. A . K^R' R ^R^C£R, väri R1 och R2 är grupper som avger elektroner, L har samma betydelse som i krav 7, och .. skyddsgruppen R är vald bland en grupp som bestär av gruppema Fmoc, Boc eller Bsmoc, • · • · · :. 5 och R” är en alkylester eller en allylester, och väri Z är antingen O eller S, och G' är en • · • ·· ester eller en amid av en karboxyl- eller sulfonsyra. • · · • « · ··♦ • · • · .·** 11. Kelaterande ämne, som omfattar • · 5 • ·· .···. - en strukturell kromofordel, * · 10. en kelaterande del som omfattar minst tvä karboxylsyra-eller fosfonsyragrupper eller estrar, amider eller sait därav, som är fasta tili en aromatisk enhet i den ♦ · · . * * *. strukturella kromofordelen antingen direkt eller via en cyklisk eller acyklisk ··· kolvätekedja som innehäller N samt • · · J • · ♦ , · · ·' - en reaktiv grupp A som är kopplad tili den strukturella kromofordelen eller tili den • · ··· ^ 15 kelaterande delen antingen direkt eller via en linker L, varvid gruppen A ♦ · · • · « * . tillhandahäller bindning tili en biomolekyl eller tili en funktionell grupp pä en fast • · « • · · fas, varvid i. den reaktiva gruppen A är Z2-0-PZ3-0-R5 5 vari en eller tvä syreatomer eventuellt är ersatta med svavel, Z3 är klor eller NR6R7, R5 är en skyddsgrupp, R6 och R7 är alkylgrupper, som omfattar 1-8 kol, λ
10 Z är inte närvarande eller är en purinbas eller pyrimidinbas eller är vilken som heist modifierad bas som är lämplig för användning vid syntes av modifierade oligonukleotider, varvid basen är ansluten tili syreatomen via antingen a) en kolvätekedja, som är substituterad med en skyddad 15 hydroximetylgrupp eller b) en furanring eller en pyranrink eller nägon modifierad furan-eller pyranring lämplig för användning vid syntes av modifierade oligonukleotider, ii. linkem L är bildad av mellan en och tio strukturella delar, av vilka varje • · 20 strukturell del är vald ur en grupp som bestär av fenylen, alkyl en med 1-12 • · * " kolatomer, etynydiyl (-OC-), etylendiyl (-C=C-), eter (-0-), tioeter (-S-), amid • · · (-CO-NH-, -CO-NR’-, -NH-CO- och -NR’-CO-), karbonyl (-CO-), ester • · .*** (-COO-ja -OOC-), disulfid (-SS-), sulfonamid (-SO2-NH-, -S02-NR’-), sulfon • · (-SO2-), fosfat (-O-PO2-O-), diaza (-N=N-) och tertiär amin, vari R’ • · 25 representerar en alkylgrupp, som innehäller färre än 5 kolatomer, m·'·' iii. den strukturella kromofordelen omfattar en eller flera aromatiska enheter, av • · .···. vilka minst en aromatisk enhet är en pyridylgrupp som är substituerad med • · · furyl eller tienyl, vari furyl- eller tienylgruppen är substituerad med en eller Hera likadana eller olika elektronavgivande grupper och därtill eventuellt ocksa *1' 30 med karboxyl- eller sulfonsyragrupper eller estrar, amider eller sait av dessa • · · · · * * syror, G, och vari de strukturella kromofordelama är direkt kopplade tili • · · • · *···’ varandra sä att de bildar en terpyridylgrupp eller är kopplade tili varandra via en cyklisk eller icke-cyklisk kolvätekedja som innehäller N.
12. Kelaterande ämne enligt krav 11, kännetecknad avatt gruppema som avger elektroner är valda bland gruppen metyl, etyl, «-propyl, /-propyl, «-butyl, /-butyl, sec-butyl , metoxi, etoxi, «-propoxi, /-propoxi, «-butoxi, /-butoxi och .veobutoxi.
13. Kelaterande ämne enligt krav 11 eller 12, kännetecknat av att Z2 är en radikal av nägon av basema thymin, urasil, adenin, guanin eller cytosin, och basen är kopplad tili en syreatom via i) en kolvätekedja som är substituterad med en skyddad hydroximetylgrupp eller ii) en furanring som innehäller en skyddad hydroximetylgrupp i position 4 och 10 eventuellt vidare en hydroxi, en skyddad hydroxi eller en modifierad grupp i position 2.
14. Kelaterande ämne enligt krav 12, kännetecknat av att -Z2-0-P(NR6R7)-0-R5 är vald ur en grupp som bestär av strukturema o o YVCHs X) ^ DMTrO. DMTrO. DMTrO O <^° 7 ? A (/-Pr)2N'P'O^x^CN (/-Pr)2N' • · • 1·♦ | j··.. xnA 0TNT0 O^N O ;... orV 0«V r^cH, /-< DMT[° ? DMTrO O DMTrcTo DMTr0 ? :·... mu-p'o^~-c" frW,V^CN • · · 9 9 9 9 99 9 15 : V: väri - är positionen för linkem L och DMTr är dimetoxitrityl. • · · • · • · • · ·
15. Kelaterande ämne enligt krav 11, k ä n n e t e c k n a t av att det är valt ur en grupp • 9 . 1 1 1. som bestär av strukturema • · · • · · · · • · · · • · 9 9 999 r&er. ,¾. AA ΛΑ-AA r^z _ AM Α"τΊ γ"ί γνί 1«^ζ γΊ ΧΥΆ ην'"α 73 70 73 73 73 73 r2-0'Z . 73 TO 4¾. iL ^N| Nf : : : : : : K ^"R1 : : R"^ L jS Ä ,¾ <Vn ^N> <Ν> R ^~R1 oinz Jht r i Γ Ί x^z R2^R1 a R2^-ri R" R- R" R" R 2<&ri jXiJx %1 A M1 M | i R2fc>? , i N R” A l A R 1 R Λ ,^L-A \ 1 T f I Γ Ί r Ί Λ, Αν^Γ /·λ~-νΆΑ ? ^ 7? τ κ-Α,^Ί1 ^ rN\^ /νί SS SS —1 I ..R' n-—I. o o o o N^il ( R- nT" ro nT" ^ p2-~\^ ^ ^ ^ M " a1, Ai:&R, r&r, f^R- 1&„Λ Α^" AAVAA m am A r a R'^N^^ L_J ] R-'^n^^l_J ] 1 ™ x x N 11 r· ^ ll :.;· r- r^£r, r-M^?r, • · · • · · *:::’ a-l-gv\ :...: R2AAri R2AAri ·1’·· Λ A ^ M AS M A A4 U 1 AA4J-A 1 :: p n n n Γ N N N ι rNi γνί αΎί γνί .. 73 70 73 70 -°. ^°. • · · ^ ^ • » » • · • · · • · • · • · · • · • · · • · · • · • · · • · • · ·:1 5 • · · · · • · · · • · • · • · · väri R” är en alkylester eller allylester av karboxylsyra eller och R’” är en alkylgrupp och väri R1 och R2 är grupper som avger elektroner, L har samma betydelse som i krav 11 och A är -Z2-0-P(NR6R7)-0-R5 som i krav 14, Z är O eller S och G' är en karboxyl- eller 5 sulfonsyras ester eller amid.
16. Kelaterande ämneenligtkrav ll,kännetecknat avattdetärvaltur engrupp som bestär av strukturema R%R< r2%r1 ,Χν lii / J r^S / N \ L-A A·^ RfeR, :> R&VQ^R' ΛΓΛ α/λ o AtW JULg^ i 11 g- R" R*€>£R' ... 10 K K '—’ R1 ··♦ • · · • · · ] <y väri R” är en alkylester eller allylester av en karboxylsyra och R och R är grupper som • · ‘I* avger elektroner, L har samma betydelse som i krav 11 och A är -Z2-0-P(NR6R7)-0-R5 • · · *4.’ säsom i krav 14 och Z är O eller S och G' är en karboxyl- eller sulfonsyras ester eller amid. ··· 15 ··· V : 17. Biomolekyl, kännetecknad avatt den är konjugerad med en kelat enligt nägot • · • · · *. *: av kraven 1 - 5.
18. Biomolekyl, kännetecknad avatt den är konjugerad med en kelat enligt nägot av kraven 1-5, varvid biomolekylen är vald bland en grupp som bestär av oligopeptider, oligonukleotider, polysakkarider, fosfolipider, PNA, LNA, antigener, steroider, hapten, läkemedel, ligander som binder till receptorer samt lektin. 5
19. Biomolekyl enligt krav 18, kännetecknad av att den modifierade oligo- eller polynukleotiden är fosformonotioat, fosforditioat, fosforamidat och/eller en socker- eller basmodifierad oligo- eller polynukleotid.
20. Fast bärare, kännetecknad av att det är konjugerad med en kelat enligt nägot av kraven 1-5.
21. Fast bärare enligt krav 20, kännetecknad av att kelaten är immobiliserad pä den fasta bäraren antingen kovalent eller icke-kovalent. 15
22. Fast bärare som är konjugerad med ett kelat enligt krav 21, kännetecknad av att den fasta bäraren är vald bland en grupp som bestär av nanopartiklar, mikropartiklar, objektglas, plattor eller en fast fas som är lämplig for syntes av oligonukleotider eller oligopeptider. • *** 20 • · • · i «· * . 23. Stämplad biomolekyl, kännetecknad av att den har erhällits genom syntes i fast • · · • · · !’* fas genom tillsättning av kelaterande ämne enligt nägot av kraven 7 - 10 i strukturen för en • · • · .Γ* oligopeptid i en oligopeptidsyntetisator, varefter skyddsgruppema avlägsnats och • · · \.. eventuellt därtill ocksä en metalljon blivit tillsatt. • · 25
24. Stämplad oligonukleotid, kännetecknad av att den är erhällen genom syntes i i « t .···. fast fas genom att tillsätta ett kelaterande ämne enligt nägot av kraven 11-16 tili • · .·, oligonukleotidens struktur, varefter skyddsgruppema avlägsnats och eventuellt därtill • · · • · · *.* ocksä en metalljon blivit tillsatt. V 30 • · · · ·
25. Fast bärare konjugerad med en oligopeptid enligt krav 22 eller en oligonukleotid enligt • · ’···* krav 23, kännetecknat av att oligopeptiden eller oligonukleotiden är kovalent eller icke-kovalent immobiliserad pä sagda fasta bärare.
26. Fast bärare konjugerad med DNA, RNA, oligopeptid, oligonukleotid, polypeptid, polynukleotid eller protein som är stämplad med kelat enligt denna uppfinning. • · • · • · 1 • · • · • · · • t · • · · • · · • · · • · • · • · · • · • · • · · • · · • · • · • · · • · • · · • · · • · • · · • · • · • · · • · • · · • · · • · • · · * · • · • · · • · · · · • » · · • · • · • · ·
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20070677A FI120538B (sv) | 2007-09-05 | 2007-09-05 | Kelater, kelaterande föreningar och konjugater deriverad av dem |
CN200880105962.6A CN101796047B (zh) | 2007-09-05 | 2008-09-05 | 发光的镧系(iii)螯合物、螯合剂及其衍生的轭合物 |
US12/676,604 US8221719B2 (en) | 2007-09-05 | 2008-09-05 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof |
PCT/FI2008/050494 WO2009030819A1 (en) | 2007-09-05 | 2008-09-05 | Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof |
EP08805417.6A EP2195310B1 (en) | 2007-09-05 | 2008-09-05 | Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20070677 | 2007-09-05 | ||
FI20070677A FI120538B (sv) | 2007-09-05 | 2007-09-05 | Kelater, kelaterande föreningar och konjugater deriverad av dem |
Publications (3)
Publication Number | Publication Date |
---|---|
FI20070677A0 FI20070677A0 (sv) | 2007-09-05 |
FI20070677A FI20070677A (sv) | 2009-03-06 |
FI120538B true FI120538B (sv) | 2009-11-30 |
Family
ID=38572875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20070677A FI120538B (sv) | 2007-09-05 | 2007-09-05 | Kelater, kelaterande föreningar och konjugater deriverad av dem |
Country Status (5)
Country | Link |
---|---|
US (1) | US8221719B2 (sv) |
EP (1) | EP2195310B1 (sv) |
CN (1) | CN101796047B (sv) |
FI (1) | FI120538B (sv) |
WO (1) | WO2009030819A1 (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI120538B (sv) | 2007-09-05 | 2009-11-30 | Wallac Oy | Kelater, kelaterande föreningar och konjugater deriverad av dem |
EP2897967B1 (en) | 2012-09-24 | 2017-06-21 | Qi Wang | Chelates, chelating agents, conjugates derived thereof and their use |
WO2014147288A1 (en) | 2013-01-31 | 2014-09-25 | Kaivogen Oy | Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents |
CN109072280B (zh) | 2016-01-21 | 2022-10-14 | 赛录科试诊断公司 | 用于快速抗微生物剂敏感性测试的方法 |
US9834808B2 (en) | 2016-01-21 | 2017-12-05 | SeLux Diagnostics, Inc. | Methods for rapid antibiotic susceptibility testing |
CA3048213A1 (en) | 2016-12-23 | 2018-06-28 | Eric Stern | Methods for improved rapid antimicrobial susceptibility testing |
CN112250699A (zh) * | 2020-09-24 | 2021-01-22 | 桂林理工大学 | 4,4,4-三氟-1-苯基-1,3-丁二酮单核铕配合物的制备、结构及荧光 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2536783A1 (en) | 2003-08-29 | 2005-03-10 | Wallac Oy | Novel chelating agents and chelates and their use |
FI120538B (sv) | 2007-09-05 | 2009-11-30 | Wallac Oy | Kelater, kelaterande föreningar och konjugater deriverad av dem |
-
2007
- 2007-09-05 FI FI20070677A patent/FI120538B/sv active IP Right Grant
-
2008
- 2008-09-05 WO PCT/FI2008/050494 patent/WO2009030819A1/en active Application Filing
- 2008-09-05 CN CN200880105962.6A patent/CN101796047B/zh active Active
- 2008-09-05 US US12/676,604 patent/US8221719B2/en active Active
- 2008-09-05 EP EP08805417.6A patent/EP2195310B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100204442A1 (en) | 2010-08-12 |
US8221719B2 (en) | 2012-07-17 |
FI20070677A (sv) | 2009-03-06 |
EP2195310B1 (en) | 2016-06-01 |
WO2009030819A1 (en) | 2009-03-12 |
CN101796047B (zh) | 2014-12-03 |
FI20070677A0 (sv) | 2007-09-05 |
EP2195310A1 (en) | 2010-06-16 |
CN101796047A (zh) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI120538B (sv) | Kelater, kelaterande föreningar och konjugater deriverad av dem | |
AU2005280581B2 (en) | Long wavelength thiol-reactive fluorophores | |
EP1658282B1 (en) | Novel chelating agents and chelates and their use | |
US20150090936A1 (en) | Large stokes shift dyes | |
JP5818990B2 (ja) | 3つの発色団を有する発光ランタニドキレート及びそれらの使用 | |
JP5837419B2 (ja) | O6−アルキルグアニン−dnaアルキルトランスフェラーゼ及びその変異体 | |
DK3137573T3 (en) | NEW CHROMOPHORE STRUCTURES FOR LANTHANIDE CHELATES | |
WO2010055207A1 (en) | Chelating, chelating agents and conjugates deriver thereof | |
US9944657B2 (en) | Luminescent lanthanide chelates having three chromophores an their use | |
WO2014147288A1 (en) | Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents | |
JP6480579B2 (ja) | 大環状ランタニドキレートのための新規発色団構造 | |
Leygue et al. | Design of novel tripyridinophane-based Eu (iii) complexes as efficient luminescent labels for bioassay applications | |
KR101125057B1 (ko) | 물질 표지용 화합물 및 그 제조방법 | |
EP2897967A1 (en) | Chelates, chelating agents, conjugates derived thereof and their use | |
JP6924780B2 (ja) | 結合アッセイのバックグラウンド遮断剤 | |
KR101125058B1 (ko) | 물질 표지용 화합물 및 그 제조방법 | |
FI128833B (sv) | Luminiscerande lantanid(III)-kelater | |
WO2009115644A1 (en) | Lanthanide(iii) chelates comprising beta-diketones and conjugates derived thereof | |
JP2020523397A (ja) | 水溶性トリメトキシフェニルピリジン型錯化剤および対応するランタニド錯体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120538 Country of ref document: FI |